Ihuman Ebitda from 2010 to 2024

IH Stock  USD 1.73  0.01  0.58%   
Ihuman's EBITDA is increasing with slightly volatile movements from year to year. EBITDA is estimated to finish at about 180.2 M this year. For the period between 2010 and 2024, Ihuman, EBITDA quarterly trend regression had mean deviation of  65,588,011 and range of 458.4 M. View All Fundamentals
 
EBITDA  
First Reported
2017-12-31
Previous Quarter
17.5 M
Current Value
18.8 M
Quarterly Volatility
37.8 M
 
Covid
Check Ihuman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ihuman's main balance sheet or income statement drivers, such as Tax Provision of 34.8 M, Depreciation And Amortization of 6 M or Interest Expense of 13.1 M, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0117 or PTB Ratio of 1.34. Ihuman financial statements analysis is a perfect complement when working with Ihuman Valuation or Volatility modules.
  
Check out the analysis of Ihuman Correlation against competitors.

Latest Ihuman's Ebitda Growth Pattern

Below is the plot of the Ebitda of Ihuman Inc over the last few years. It is Ihuman's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ihuman's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Ihuman Ebitda Regression Statistics

Arithmetic Mean(5,921,077)
Geometric Mean42,003,451
Coefficient Of Variation(1,817)
Mean Deviation65,588,011
Median(21,698,000)
Standard Deviation107,575,789
Sample Variance11572.6T
Range458.4M
R-Value0.39
Mean Square Error10582.9T
R-Squared0.15
Significance0.15
Slope9,342,178
Total Sum of Squares162015.7T

Ihuman Ebitda History

2024180.2 M
2023171.6 M
2022122.4 M
2021-47.8 M
2020-41.6 M
2019-278.2 M

About Ihuman Financial Statements

Investors use fundamental indicators, such as Ihuman's Ebitda, to determine how well the company is positioned to perform in the future. Although Ihuman's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
EBITDA171.6 M180.2 M

Currently Active Assets on Macroaxis

Check out the analysis of Ihuman Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ihuman. If investors know Ihuman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ihuman listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Earnings Share
(0.16)
Revenue Per Share
18.263
Quarterly Revenue Growth
(0.11)
Return On Assets
0.0456
The market value of Ihuman Inc is measured differently than its book value, which is the value of Ihuman that is recorded on the company's balance sheet. Investors also form their own opinion of Ihuman's value that differs from its market value or its book value, called intrinsic value, which is Ihuman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ihuman's market value can be influenced by many factors that don't directly affect Ihuman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ihuman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ihuman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ihuman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.